000 03258nam a22005175i 4500
001 978-1-84882-710-3
003 DE-He213
005 20140220082506.0
007 cr nn 008mamaa
008 140130s2014 xxk| s |||| 0|eng d
020 _a9781848827103
_9978-1-84882-710-3
024 7 _a10.1007/978-1-84882-710-3
_2doi
050 4 _aR1
072 7 _aMB
_2bicssc
072 7 _aMED000000
_2bisacsh
082 0 4 _a610
_223
100 1 _aMiller, Colin G.
_eeditor.
245 1 0 _aMedical Imaging in Clinical Trials
_h[electronic resource] /
_cedited by Colin G. Miller, Joel Krasnow, Lawrence H. Schwartz.
264 1 _aLondon :
_bSpringer London :
_bImprint: Springer,
_c2014.
300 _aXVIII, 420 p. 111 illus., 57 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
520 _aMedical Imaging in Clinical Trials is a key text in understanding the methodology and the metrics that are required in the field of medical imaging. As the pharmaceutical, biotech and medical device industries continue to identify ways to improve and speed up product development, medical imaging plays a more significant role. Medical Imaging in Clinical Trials aims to educate and provide a hands-on text for those involved in clinical trials and either new to medical imaging and having to assimilate it into clinical trials or requiring to understand the key differences between clinical trial imaging and “routine” clinical imaging.  It is targeted to those professionals involved in clinical trials at the clinical research site, pharmaceutical and medical device industries, and regulators.  This is not the “how to image” book written for the radiologist or Radiological Technologist, but covers the critical aspects of clinical trial methodology that are important for these individuals to understand. This book addresses the ethics and radiation dosages of the different modalities, the end points commonly used for the different trial phases, the acquisition and analysis techniques, as well as the logistics management of medical imaging and the role of the central imaging lab or imaging core lab (ICL) which is now the standard requirement for clinical trials.  Furthermore this text delves into the details of the major therapeutic areas where medical imaging plays a primary or secondary efficacy or safety end point.
650 0 _aMedicine.
650 0 _aRadiology, Medical.
650 0 _aInterventional radiology.
650 0 _aNuclear medicine.
650 0 _aDiagnosis, Ultrasonic.
650 1 4 _aMedicine & Public Health.
650 2 4 _aMedicine/Public Health, general.
650 2 4 _aImaging / Radiology.
650 2 4 _aDiagnostic Radiology.
650 2 4 _aNuclear Medicine.
650 2 4 _aInterventional Radiology.
650 2 4 _aUltrasound.
700 1 _aKrasnow, Joel.
_eeditor.
700 1 _aSchwartz, Lawrence H.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781848827097
856 4 0 _uhttp://dx.doi.org/10.1007/978-1-84882-710-3
912 _aZDB-2-SME
999 _c92431
_d92431